Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ONCREGN

BeOne Medicines AG

ONC · $376.82

74Good

Regeneron Pharmaceuticals, Inc.

REGN · $782.04

73Good

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ONC

74/100

REGN

73/100

Quality

Is it a profitable, well-run business?

ONC

4.6/10

REGN

6.2/10

Growth

Is the company growing?

ONC

9.8/10

REGN

4.5/10

Valuation

Is the price reasonable? (higher = cheaper)

ONC

3.4/10

REGN

6.9/10

Risk

How risky are the shares? (higher = lower risk)

ONC

7.6/10

REGN

8.1/10

Momentum

Is the share price trending up?

ONC

9.4/10

REGN

8.4/10

Financial strength

Is the balance sheet healthy?

ONC

8.1/10

REGN

9.7/10

The balanced view

Model-generated

BeOne Medicines AG

This company scores above average, with solid growth and a positive price trend, although its current valuation deserves attention.

Leads on: growth, momentum

Best feature: solid growth (Revenue growth (FY): 40.2%)

Watch out: valuation may be demanding (DCF upside: -1062.0%)

Regeneron Pharmaceuticals, Inc.

This company scores above average, with a healthy balance sheet and a positive price trend.

Leads on: quality, valuation, risk, financial strength

Best feature: healthy balance sheet (Altman Z-Score: 7.29)

Watch out: weakest area: growth potential (Revenue growth (FY): 1.0%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.